A comorbid patient: rheumatoid arthritis and hypertension

DOI: https://doi.org/10.29296/25877305-2020-03-05
Download full text PDF
Issue: 
3
Year: 
2020

I. Bazina(1), Candidate of Medical Sciences; Professor O. Kozyrev(1), MD; M. Pavlova(1); D. Krechikova(2), Candidate of Medical Sciences; E. Mizyova(1); D. Pak(1); N. Petrunina(1) (1)Smolensk State Medical University (2)Departmental Hospital at the Smolensk Station, OAO «RZhD», Smolensk

Pathology of the cardiovascular system occupies the leading place in the structure of comorbid diseases. According to the data available in the literature, hypertension is noted in 60% of patients with rheumatoid arthritis (RA); however, the relationship between RA activity and blood pressure levels has been insufficiently studied. The paper discusses the features of the course of hypertension in patients with RA, as well as the relationship between autoimmune inflammation and hypertension.
Keywords: 
cardiology
rheumatology
comorbidity
hypertension
rheumatoid arthritis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vertkin A.L., Rumjantsev M.A., Skotnikov A.S. i dr. Komorbidnost' // Vestnik semejnoj meditsiny. – 2011; 3: 40–7 [Vertkin A.L., Rumyantsev M.A., Skotnikov A.S. i dr. Komorbidnost’ // Vestnik semeinoi meditsiny. – 2011; 3: 40–7 (in Russ.)].
  2. Gordeev A.V., Galushko E.A., Nasonov E.L. Kontseptsija mul'timorbidnosti v revmatologicheskoj praktike // Nauchno-prakticheskaja revmatologija. – 2014; 52 (4): 362–5 [Gordeev A.V., Galushko E.A., Nasonov E.L. The concept of multimorbidity in rheumatologic practice // Rheumatology Science and Practice. – 2014; 52 (4): 362–5 (in Russ.)]. https://doi.org/10.14412/1995-4484-2014-362-365.
  3. Panafidina T.A., Kondrat'eva L.V., Gerasimova E.V. i dr. Komorbidnost' pri revmatoidnom artrite // Nauchno-prakticheskaja revmatologija. – 2014; 52 (3): 283–9 [Panafidina T.A., Kondratyeva L.V., Gerasimova E.V. et al. Comorbidity in rheumatoid arthritis // Rheumatology Science and Practice. – 2014; 52 (3): 283–9 (in Russ.)]. https://doi.org/10.14412/1995-4484-2014-283-289.
  4. Nikitina N.M., Afanas'ev I.A., Romanova T.A. i dr. Osobennosti komorbidnosti u bol'nyh revmatoidnym artritom v raznye gody nabljudenija // Sovremennaja revmatologija. – 2015; 9 (1): 39–43 [Nikitina N.M., Afanasyev I.A., Romanova T.A., et al. Specific features of comorbidity in rheumatoid arthritis patients in different follow-up years // Modern Rheumatology Journal. – 2015; 9 (1): 39–43 (in Russ.)]. https://doi.org/10.14412/1996-7012-2015-1-39-41.
  5. Profilaktika, diagnostika i lechenie pervichnoj arterial'noj gipertonii v Rossijskoj Federatsii. Pervyj Doklad ekspertov nauchnogo obschestva po izucheniju arterial'noj gipertonii Vserossijskogo nauchnogo obschestva kardiologov i Mezhvedomstvennogo soveta po serdechno-sosudistym zabolevanijam (DAG-I) // Klinicheskaja farmakologija i terapija. – 2000; 3: 5–30 [Profilaktika, diagnostika i lechenie pervichnoi arterial’noi gipertonii v Rossiiskoi Federatsii. Pervyi Doklad ekspertov nauchnogo obshchestva po izucheniyu arterial’noi gipertonii Vserossiiskogo nauchnogo obshchestva kardiologov i Mezhvedomstvennogo soveta po serdechno-sosudistym zabolevaniyam (DAG-I) // Klinicheskaya farmakologiya i terapiya. – 2000; 3: 5–30 (in Russ.)].
  6. Casale P., Devereux R., Milner M. et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men // Ann. Int. Med. – 1986; 105: 173–8.
  7. Meune C., Touze E., Trinqurte L. et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analisis of cohort studies // Rheumatology. – 2009; 48 (10): 1309–13. DOI: 10.1093/rheumatology/kep252.
  8. Popkova T.V., Novikova D.S., Nasonov E.L. Ateroskleroz pri revmaticheskih zabolevanijah. Revmatologija: klinicheskie rekomendatsii / M.: GEOTAR-Media, 2010; s. 678–702 [Popkova T.V., Novikova D.S., Nasonov E.L. Ateroskleroz pri revmaticheskikh zabolevaniyakh. Revmatologiya: klinicheskie rekomendatsii / M.: GEOTAR-Media, 2010; s. 678–702 (in Russ.)].
  9. Rossijskie rekomendatsii po diagnostike i lecheniju arterial'noj gipertenzii. Natsional'nye klinicheskie rekomendatsii: Sb. Pod red. R.G. Oganova. 2-e izd. / M.: Silitseja-Poligraf, 2009; s. 292–332 [Rossiiskie rekomendatsii po diagnostike i lecheniyu arterial’noi gipertenzii. Natsional’nye klinicheskie rekomendatsii: Sb. Pod red. R.G. Oganova. 2-e izd. / M.: Silitseya-Poligraf, 2009; s. 292–332 (in Russ.)].
  10. Popkova T.V., Novikova D.S., Pisarev V.V. i dr. Faktory riska kardiovaskuljarnyh zabolevanij pri revmatoidnom artrite // Nauchno-prakticheskaja revmatologija. – 2009; 47 (3): 4–11 [Popkova T.V., Novikova D.S., Pisarev V.V. et al. Risk factors of cardiovascular diseases in rheumatoid arthritis // Rheumatology Science and Practice. – 2009; 47 (3): 4–11 (in Russ.)]. https://doi.org/10.14412/1995-4484-2009-1306.
  11. Del Rincon I., Freeman G., Haas R. et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis // Arthritis & Rheumatology. – 2005; 52: 3413–23. DOI: 10.1002/art.21397.
  12. Korjagina N.V., Mjasoedova S.E., Lebedeva O.V. i dr. Osobennosti arterial'noj gipertonii pri revmatoidnom artrite. Sb. Mat-lov V s'ezda revmatologov Rossii, 2009; s. 57 [Koryagina N.V., Myasoedova S.E., Lebedeva O.V. et al. Osobennosti arterial’noi gipertonii pri revmatoidnom artrite. Sb. Mat-lov V s»ezda revmatologov Rossii, 2009; s. 57 (in Russ.)].
  13. Assous N., Touze E., Meune C. et al. Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France // Joint Bone Spine. – 2007; 74: 66–72. DOI: 10.1016/j.jbspin.2006.10.001.
  14. Naranjo A., Sokka T., Descalzo M. et al. QUEST-RA Group. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study // Arthritis Research& Therapy. – 2008; 1: 30. DOI: 10.1186/ar2383.
  15. Panoulas V., Douglas K., Milionis H. et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis // Rheumatology. – 2007; 46: 1477–82. DOI: 10.1093/rheumatology/kem169.
  16. Nikitina N.M., Rebrov A.P. Arterial'naja gipertonija u bol'nyh revmatoidnym artritom // Ratsional'naja farmakoterapija v kardiologii. – 2009; 3: 67–70 [Nikitina N.M., Rebrov A.P. Arterial hypertension in patients with rheumatoid arthritis // Ratsional’naya farmakoterapiya v kardiologii. – 2009; 3: 67–70 (in Russ.)].
  17. Del Rincon I., Williams K., Stern M. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors // Arthritis & Rheumatology. – 2001; 44 (12): 2737–45. DOI: 10.1002/1529-0131(200112)44:123.0.co;2-#.
  18. Panoulas V., Metsios G., Pace A. et al. Hypertension in rheumatoid arthritis // Rheumatology. – 2008; 47: 1286–98. DOI: 10.1093/rheumatology/ken159.
  19. Blake G., Rifai N., Buring J. et al. Blood pressure, C-reactive protein, and risk of future cardiovascular events // Circulation – 2003; 108: 2993–9. DOI: 10.1161/01.CIR.0000104566.10178.AF.
  20. Poole C., Conway P., Currie C. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice // Rheumatology. – 2009; 48: 78–82. DOI: 10.1093/rheumatology/ken415.
  21. Wang C., Li S., Weisel R. et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle // Circulation. – 2003; 107: 1783–90. DOI: 10.1161/01.CIR.0000061916.95736.E5.
  22. Tomasson G., Aspelund T., Jonsson T. et al. Effect of rheumatoid factor on mortality and coronary heart disease // Ann. Rheum. Dis. – 2010; 69 (9): 1649–54. DOI: 10.1136/ard.2009.110536.
  23. Goodson N., Willes N., Lunt N. Mortality on early inflammatory arthritis: cardiovascular mortality in seropositive patients // Arthritis & Rheumatology. – 2002; 46: 2010–19.
  24. Novikova D.S., Popkova T.V., Aleksandrova E.N. i dr. Rol' antitel k tsiklicheskomu tsitrullinirovannomu peptidu (ATsTsP) i modifitsirovannomu tsitrullinirovannomu vimentinu (AMTsV) v razvitii ateroskleroticheskogo porazhenija sosudov pri revmatoidnom artrite. Sb. mat-lov V s'ezda revmatologov Rossii, 2009; c. 57 [Novikova D.S., Popkova T.V., Aleksandrova E.N. et al. Rol’ antitel k tsiklicheskomu tsitrullinirovannomu peptidu (ATsTsP) i modifitsirovannomu tsitrullinirovannomu vimentinu (AMTsV) v razvitii ateroskleroticheskogo porazheniya sosudov pri revmatoidnom artrite. Sb. mat-lov V s»ezda revmatologov Rossii, 2009; c. 57 (in Russ.)].
  25. Giles J., Malayeri A., Fernandes V. et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging // Arthritis & Rheumatology. – 2010; 62 (4): 940–51. DOI: 10.1002/art.27349.
  26. IOF Word Congress on Osteoporosis and 10th European Congress of Clinical and Economic aspect of Osteoporosis and Osteoarthritis. IOF Word Congress // Osteoporosis Int. – 2010; 21 (Suppl. 1): 25–388. https://doi.org/10.1007/s00198-010-1247-9.
  27. Harvey N., Dennison E., Cooper C. Osteoporosis: impact on health and economics // Nat. Rev. Rheumatol. – 2010; 6 (suppl. 1): 99–105. http://dx.doi.org/10.1038/ nrrheum.2009.260.
  28. Tanko L., Christiansen C., Cox D. et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women // JBMR. – 2005; 20 (11): 1912–20. http://dx.doi.org/10.1359/JBMR.050711.
  29. Hak A., Pols H., van Hemert A. et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study // Arteriosclerosis, Thrombosis, and Vascular Biology. – 2000; 20 (8): 1926–31. http://dx.doi.org/10.1161/01.ATV.20.8.1926.
  30. Karouzakis E., Neidhart M., Gay R. et al. Molecular and cellular basis of rheumatoid joint destraction // Immunology Letters. – 2006; 106 (1): 8–13. http://dx.doi.org/10.1016/j.imlet. 2006.04.011.
  31. Hall F., Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin // Rheumatology. – 2005; 44: 1473–82. DOI: 10.1093/rheumatology/kei012.